Advertisements

Hexymer

Quick links to important sections

Hexymer

Advertisements

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Hexymer

What is Hexymer? (Trihexyphenidyl)

Property Description
Active Ingredient Trihexyphenidyl Hydrochloride
Pharmacological Class Anticholinergic Agent
Primary Therapeutic Class Antiparkinson Agent
Dosage Forms Tablet, Oral Solution
Origin Synthetic (Small Molecule)

Hexymer is the trade name for the prescription-only synthetic medication whose active substance is Trihexyphenidyl Hydrochloride (Trihexyphenidyl HCl). This compound is formally classified as a centrally acting Anticholinergic Agent and therapeutically as an Antiparkinson Agent.

Identity, Origin, and Mechanism of Action

Hexymer's core function is that of a non-selective Muscarinic Antagonist, meaning it works by blocking the excessive signaling of the neurotransmitter acetylcholine in the central nervous system. It acts by counteracting the cholinergic imbalance associated with certain movement disorders. The substance is synthesized as a racemate, a chemical property that defines its overall activity.

This single-ingredient product is distinguished within its class by its availability as both a solid tablet and a liquid oral solution (elixir). This dual formulation is key for precise dosage titration and administration via the oral route, accommodating patients who may struggle with swallowing solid medications.

General Therapeutic Purpose

Hexymer functions to help stabilize the chemical environment in the areas of the brain that govern muscle movement. By exerting its antispasmodic effect, the medication lessens the impact of excessive nerve impulses. This action generally helps to mitigate the undesirable involuntary movements, muscle stiffness, and tremors that are symptomatic of Parkinsonism and drug-induced Extrapyramidal Symptoms. It remains a standard option for managing these specific movement difficulties.

Regulatory References

  1. WHO Essential Medicines List
Advertisements

What side effects are possible with Hexymer?

Possible Side Effects and Safety Information

The official safety profile for Hexymer (Trihexyphenidyl) is characterized by adverse reactions primarily resulting from its anticholinergic activity, as documented in regulatory sources like the FDA Prescribing Information and the SmPC.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by their expected frequency:

  • Common/Minor (experienced by 30% to 50% of patients): Dry mouth (xerostomia), blurred vision, dizziness, mild nausea, and nervousness. These effects may lessen over time as the body develops tolerance.
  • Rare: Isolated instances of serious events are reported, including paralytic ileus, dilatation of the colon, suppurative parotitis, and psychiatric manifestations like delusions or hallucinations.

System-Organ-Class Effects and Serious Reactions

Adverse reactions are documented across several physiological systems. Key anticholinergic effects involve the Gastrointestinal System (constipation, urinary retention), Eye Disorders (dilation of pupils, loss of accommodation), and the Nervous System (drowsiness, confusion).

Serious adverse reactions officially noted include the risk of precipitating Acute Angle-Closure Glaucoma (a concern particularly with long-term use) and Hyperthermia/Heat Stroke due to the drug's effect of decreased sweating (anhidrosis). Neuroleptic Malignant Syndrome (NMS) has been reported in association with the abrupt withdrawal of treatment.


Population-Specific Safety Considerations

Regulatory documents emphasize increased susceptibility to anticholinergic effects in older adults (geriatric patients) over age 60, who may be more prone to mental confusion, memory impairment, and urinary retention. Caution is necessary for individuals with pre-existing conditions such as glaucoma and obstructive diseases of the gastrointestinal or genitourinary tracts. The necessity of gradual withdrawal is explicitly stated to prevent the exacerbation of symptoms or the risk of NMS.

Advertisements

Overdose and Emergency Response

Overdose with Hexymer (Trihexyphenidyl) is officially documented as a state of severe central anticholinergic toxicity. The clinical manifestations listed in regulatory labeling include significant neurological effects such as profound agitation, confusion, delirium, hallucinations, paranoia, and severe drowsiness. Physical signs commonly associated with overdose include mydriasis (dilated pupils), hyperthermia (high body temperature), redness of the face, extreme dryness of the skin and mucous membranes, poor coordination, and tachycardia (rapid heart rate).

These presentations can escalate rapidly to life-threatening outcomes. Official regulatory documents list the most severe complications as respiratory depression and cardiac arrest. Immediate emergency medical attention is required upon the suspicion or manifestation of any overdose event. Regulators mandate contacting emergency services or a Poison Help line immediately due to the documented potential for death if the overdose is untreated.

Untreated overdose carries a risk of death, which is noted to be particularly elevated in children. Additionally, geriatric patients (those over 60 years of age) are officially documented as potentially having increased sensitivity to the effects of this type of drug, which is a key consideration in overdose scenarios. Management focuses on symptomatic and supportive care.

Advertisements

Therapeutic Uses of Hexymer

Hexymer (Trihexyphenidyl) is commonly used in situations involving certain distressing symptoms across two primary therapeutic areas. It is relevant for managing symptoms that interfere with daily comfort related to parkinsonism and drug-induced movement issues.


Controlling Tremor and Rigidity in Parkinsonism

Hexymer is generally applied across conditions characterized by periods of heightened symptoms such as Parkinson’s disease and related parkinsonism. It plays a role in managing symptoms of increased neurological or muscular activity, specifically the involuntary shaking (tremor) and muscle stiffness (rigidity). This application assists with maintaining a sense of stability and contributes to improved comfort during periods of heightened symptoms.


Managing Drug-Induced Extrapyramidal Symptoms (EPS)

It is applied in clinical settings that involve acute or unstable symptom patterns, specifically for Extrapyramidal Symptoms (EPS) caused by certain central nervous system drugs. It helps address symptom clusters that may become intense or disruptive, such as sudden, severe muscle twisting (dystonia). This use provides support that helps ease the overall symptom burden and supports the patient during difficult episodes by easing distress when symptoms become temporarily overwhelming.


Quick Fact: This medication is relevant for managing symptoms that interfere with daily comfort related to movement disorders.

Regulatory References

  1. NIH DailyMed Drug Label for Trihexyphenidyl
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Hexymer?

Hexymer (pirfenidone) is formally restricted to specific adult populations based on regulatory health authority guidelines (such as the FDA, EMA, and Health Canada). These guidelines establish clear rules for eligibility and absolute contraindications.

Eligibility Exclusions (Contraindications)

The medicine must not be used in patients with the following conditions:

Contraindicated Group Limitation Basis
Severe Hepatic Impairment Child-Pugh Class C or End-Stage Liver Disease.
Severe Renal Impairment Creatinine Clearance <30 mL/min or End-Stage Renal Disease requiring dialysis.
Hypersensitivity Known allergy to pirfenidone or its excipients.
Concomitant Fluvoxamine Use Co-administration of this specific strong CYP1A2 inhibitor.

Restricted and Non-Established Use

  • Age: The medicine is restricted to adult patients (age 18 and older). Safety and effectiveness have not been established in pediatric patients.
  • Organ Function: Patients with mild or moderate hepatic or renal impairment may use the medicine but require caution and close monitoring.
  • Reproductive Status: Use during pregnancy should generally be avoided. For lactating women, a decision must be made to discontinue breastfeeding or discontinue the medicine.
  • Smoking: Patients who smoke should be advised to stop smoking, as smoking may reduce the drug's efficacy.
Advertisements

What should I know about interactions with other medicines?

Documented Interactions with Other Medicines and Products

The regulatory interaction profile for Trihexyphenidyl (Hexymer) is primarily characterized by pharmacodynamic effects resulting from its anticholinergic activity. All listed interactions are based on official government prescribing information.

1. Additive Anticholinergic Effects Co-administration with other Parasympathetic Inhibitors or agents like Tricyclic Antidepressants, Phenothiazines, and Clozapine may intensify anticholinergic activity, increasing the risk for effects such as dry mouth or urinary retention. This additive effect is formally documented in government prescribing information and requires consideration.

2. Additive Central Nervous System (CNS) Depression Hexymer has an additive effect with other CNS depressants, including Alcohol, Opiates, and Barbiturates, which is officially described as increasing the potential for sedative effects. Official documents advise against alcohol use due to this documented risk of additive CNS depression.

3. Antagonism and Exposure Alteration The drug can interfere with the function of the gastrointestinal tract. This antagonism can reduce the intended effects of GI-motility agents such as Metoclopramide and Domperidone. Furthermore, the co-administration with Levodopa may reduce the absorption and therapeutic effects of Levodopa. Dose reduction of each agent may be necessary in this context.

4. Population-Specific Considerations Regulatory documents note that elderly patients have an increased risk for interaction-related severe outcomes, such as acute glaucoma or paralytic ileus, when combining Hexymer with certain other medications.

Advertisements

Mechanism of Action

Hexymer, containing trihexyphenidyl, functions as a tertiary amine anticholinergic agent that acts primarily as a muscarinic acetylcholine receptor antagonist. The molecule readily crosses the blood-brain barrier, exhibiting its primary pharmacological activity within the central nervous system (CNS), particularly accumulating in motor control regions such as the striatum.

Its main biological targets are the muscarinic acetylcholine receptors (mAChRs), notably displaying a higher binding affinity for the M1 and M4 subtypes. By competitively binding to these receptors, trihexyphenidyl blocks the neurotransmitter acetylcholine from initiating post-synaptic signaling. This inhibitory interaction decreases the influence of the cholinergic system in the striatum, which is pathologically overactive in certain movement disorders.

This modulation re-establishes a relative balance between the cholinergic and dopaminergic signaling pathways in the basal ganglia. The downstream cascade involves a reduction in efferent impulses within the parasympathetic nervous system, leading to diminished acetylcholine-mediated excitation. At a systemic level, this translates into a modulation of muscle tone and a decrease in involuntary motor activity.

Advertisements

Dosage and Administration Information

How to use Hexymer (Trihexyphenidyl) — Administration Guidelines

Hexymer (Trihexyphenidyl) is an oral medication available as tablets or an elixir. The dosage must be individualized based on the patient's response and should always be initiated at a low level.

Administration and Dosage Rules

Guideline Instruction
Route & Forms Oral administration (Tablets or Elixir/Oral Solution).
Initial Dose Should be low, such as 1 mg on the first day.
Dose Titration Increase the dose gradually, typically by 1 mg or 2 mg increments every 3 to 5 days, until the optimal level is reached.
Dosing Frequency The total daily dose is best tolerated when divided into three or four doses and taken throughout the day, often at mealtimes.
Timing with Meals May be taken before or after meals. Taking it before meals may help if the medication causes excessive dry mouth. Taking it with food or after meals is advised if it causes nausea.

Special Procedural Instructions

  • Elderly Patients: Patients over 60 years of age require a lower initial dose and particularly gradual increases to reach the optimal level.
  • Discontinuation: The medication must not be stopped abruptly. Abrupt cessation or rapid dose reduction should be avoided to prevent a severe rebound.
  • Concomitant Use: When used alongside levodopa, the usual dose of each medication may need to be reduced. Trihexyphenidyl dosage of 3 mg to 6 mg daily, in divided doses, is usually considered adequate.

This structured protocol follows a cautious, empirical approach to establishing the correct dose for each individual while outlining the necessary procedure for gradual dose adjustment and discontinuation.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Hexymer


Evidence for use in Parkinsonism

Research pertaining to Hexymer was conducted in patients with parkinsonism, including Parkinson's disease, relying primarily on older Randomized Controlled Trials (RCTs) and observational studies. Researchers examined changes in motor symptoms, such as tremor and muscle rigidity, using standardized rating scales. Findings describe patterns observed in these studies, including measurements related to the tremor component of the condition. The evidence supporting the research is generally observed to be moderate in consistency, largely because supporting trials were conducted before modern rigorous standards were established. Research also examined the medication's use as adjunctive therapy alongside other treatments.


Evidence for use in Drug-Induced Extrapyramidal Symptoms (EPS)

For Drug-Induced Extrapyramidal Symptoms (EPS), the evidence record includes short-term randomized controlled trials focused on episodes where symptoms become noticeable, such as sudden muscle twisting (acute dystonia). Studies monitored outcomes describing episodic changes and tracked the reduction in movement intensity. Research involving Hexymer reflects consistent data; the supporting trials are generally considered high quality in consistency based on historical records. However, comparative evidence is lacking when examining its use alongside newer classes of medications.


Research Gaps and Uncertainties

The evidence record highlights limitations, particularly concerning long-term use. The controlled efficacy trials generally had limited follow-up durations, often lasting only weeks or months, meaning the long-term stability of observed outcomes is less characterized by large-scale, controlled research. Furthermore, the results apply only to the studied adult populations, and the data for certain groups, such as older adults, remain insufficient to draw broad conclusions. There is also limited insight into whether Hexymer was studied as a preventative measure against EPS.

Key Studies & References

  1. Label: TRIHEXYPHENIDYL HYDROCHLORIDE solution/tablet - DailyMed
  2. Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Hexymer (FAQ)


Q: Is it normal to feel tired when first starting Hexymer?

A: Official drug information notes that tiredness, weakness, and drowsiness are reported adverse reactions. These effects are associated with the drug's activity on the nervous system. The frequency of feeling tired is not precisely defined in regulatory documents, but anticholinergic agents can sometimes cause similar effects.


Q: Can Hexymer be taken with Tylenol (acetaminophen)?

A: Hexymer's primary activity can affect the speed at which medications move through the gastrointestinal tract. This means it may slightly delay the body's absorption of other medicines, including acetaminophen (Tylenol). Information regarding the timing and use of this combination should be discussed with a healthcare professional.


Q: Is it okay to take Hexymer with multivitamins?

A: Standard multivitamins are not specifically listed as interacting with Hexymer in official regulatory documents. Official patient safety information typically states the importance of a healthcare professional being aware of all medications, including nonprescription vitamins, supplements, and herbal products.


Q: Why is the research evidence for Hexymer described as 'limited' or 'ongoing'?

A: The official clinical records indicate that controlled efficacy trials supporting Hexymer often had short follow-up durations, sometimes lasting only weeks or months. This suggests that while short-term benefits are documented, the long-term stability of the observed outcomes is less fully characterized by large-scale, long-duration research.


Q: Can I take Hexymer if I have a history of [common organ] problems?

A: Hexymer is described as requiring caution in certain patients, particularly those with narrow angle glaucoma, or obstructive diseases in the digestive or urinary systems. The medication’s use in patients with cardiac, liver, or kidney disorders requires close monitoring, as noted in regulatory warnings.


Q: Is Hexymer addictive?

A: Regulatory documents include a 'Drug Abuse and Dependence' section, noting that indiscriminate use may lead to overdosage, causing psychiatric disturbances or feelings of euphoria. Regulatory documents indicate that abrupt cessation of the drug is generally avoided to prevent the possibility of acute exacerbation of symptoms.


Q: Can Hexymer affect my sleep?

A: Official safety information reports that some patients experience trouble sleeping, which is known as insomnia. Additionally, drowsiness is a recognized common side effect, which may indirectly influence sleep patterns.


Q: What are the official restrictions on who can use Hexymer?

A: Official restrictions formally exclude patients with a known hypersensitivity (allergy) to the drug or its components, and those with narrow-angle glaucoma. Special caution is also directed toward older patients due to their increased susceptibility to certain anticholinergic side effects.


Q: Are there any long-term effects of taking Hexymer?

A: Regulatory documents acknowledge that some patients may use the medication long-term. They require careful monitoring for untoward reactions, including the risk of angle-closure glaucoma, which has been reported to occur after long-term use.


Q: What should I do if I have a mild rash after starting Hexymer?

A: Skin rash is listed as a rare, reported side effect in official safety documents. Patient information emphasizes that any signs of an allergic reaction, such as a rash, are typically communicated to a healthcare professional.


Q: What is the purpose of the black box warning on Hexymer, if there is one?

A: The drug Hexymer (Trihexyphenidyl) does not have a US FDA Black Box Warning. This means the product is approved with the standard set of Warnings and Precautions detailed in the official prescribing information.


Q: Are there generic versions of Hexymer available?

A: Hexymer is the brand name for the generic drug trihexyphenidyl hydrochloride. Official drug information confirms that the generic form of trihexyphenidyl is widely available for prescription.


Q: Can I drive or operate machinery while taking Hexymer?

A: Regulatory documents explicitly caution that Hexymer may impair the mental and/or physical abilities necessary for performing hazardous tasks. Patients should ensure that their therapy does not negatively affect their motor or cognitive abilities before driving or operating machinery.


Q: Is there a maximum time someone can stay on Hexymer?

A: The official label does not set a maximum treatment duration and notes that use may, in some instances, continue indefinitely. However, due to its properties, continuous and careful patient monitoring is necessary during long-term treatment.


Q: Do I need to change my diet while on Hexymer?

A: Official documents explicitly advise patients to avoid consuming alcohol due to the potential for increased sedative effects. Aside from this, no specific general dietary changes are mandated, but taking the medication with food can help if nausea is experienced.


Q: Can Hexymer interact with herbal supplements?

A: Patient safety information advises disclosing all medications and supplements, including herbal products, to a healthcare professional. There are no specific herbal interactions formally listed in the drug's official interaction profile.


Q: Is it common for people to switch from another drug to Hexymer?

A: Hexymer is officially approved to manage extrapyramidal reactions that can arise from other medicines, such as antipsychotics. Regulatory guidelines describe how its dosage may be adjusted when it is used alongside or to replace a different medicine.


Q: What is the official success rate or expected outcome of Hexymer treatment?

A: Official regulatory information notes that the goal of treatment is to reach the optimal dosage level that results in a satisfactory control of symptoms. The expected outcome is the modulation of muscle tone and a decrease in involuntary motor activity (tremor and rigidity) symptomatic of the condition.


Q: Can Hexymer cause anxiety?

A: Official safety information lists Anxiety as an adverse reaction reported in some patients. This is separate from nervousness, which is also listed as a common side effect of the drug.


Q: Are there any required tests before starting Hexymer?

A: Regulatory documents state that due to the risk of angle-closure glaucoma, patients should receive a gonioscope evaluation and have their intraocular pressures monitored at regular intervals during treatment.


Q: Can pregnant women use Hexymer?

A: Hexymer is designated as Pregnancy Category C by the FDA, indicating that use during pregnancy is generally not recommended unless clearly needed by the patient. This classification is based on the absence of adequate and well-controlled studies in human pregnancy.


Q: Is it safe to breastfeed while taking Hexymer?

A: Official consensus is that the potential benefit of the drug must be weighed against the potential risk to the nursing infant when considering use during lactation. Anticholinergic agents may suppress milk production, and some authorities advise caution as infants may be sensitive to the drug’s effects.


Q: Is the mechanism of action of Hexymer fully understood by scientists?

A: Regulatory documents provide a definitive and detailed explanation of how the drug works. Hexymer is classified as a tertiary amine anticholinergic agent that functions by blocking muscarinic acetylcholine receptors in the central nervous system.

Advertisements

How should Hexymer be stored and disposed of?

How to Store and Dispose of Hexymer

Official regulatory guidelines strictly define the necessary conditions for storing Trihexyphenidyl Hydrochloride (Hexymer) to maintain its stability.

Storage Requirements

Trihexyphenidyl tablets must be stored at a Controlled Room Temperature (CRT), specifically 20 C to 25 C (68 F to 77 F). The medication must be kept in a tight container and, in some formulations, a light-resistant container. The oral solution formulation must be protected from freezing and should not be frozen.

All forms of this medicine must be kept out of the sight and reach of children and are typically supplied with a child-resistant closure.

Disposal Instructions

Unused or expired Hexymer should be disposed of through a dedicated drug take-back program. If no program is available, the product should be mixed with an undesirable substance, sealed in a bag or container, and discarded in the household trash, following official FDA guidelines. This medication is not to be flushed down the toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hexymer found in:

A-Z Index: